[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341625-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341625-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","single-molecule-epiallelic-profiling-of-dna-derived-from-routinely-collected-pap-specimens-for-noninvasive-detection-of-ovarian-cancer","Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer","","Single-molecule epiallelic profiling is presented as a strategy to detect rare ovarian-cancer-specific DNA methylation aberrations from routinely collected cervical Pap specimens. PapDREAM uses a microfluidic platform for highly parallelized digital high-resolution melt, enabling locus-specific methylation analysis on a molecule-by-molecule basis at or near single CpG-site resolution. The method aims to achieve high sensitivity and specificity while operating at a fraction of the cost of next-generation sequencing. Feasibility is evaluated using DNA from 43 women, including 18 cancer cases, by assessing intermolecular methylation heterogeneity across a biomarker locus panel.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/single-molecule-epiallelic-profiling-of-dna-derived-from-routinely-collected-pap-specimens-for-noninvasive-detection-of-ovarian-cancer/341625/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/single-molecule-epiallelic-profiling-of-dna-derived-from-routinely-collected-pap-specimens-for-noninvasive-detection-of-ovarian-cancer/341625.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does PapDREAM address for ovarian cancer detection?","Question",{"text":63,"@type":64},"It targets reliable detection of rare, tumor-specific DNA methylation aberrations from low-cost, routinely collected Pap specimens, especially for early-stage disease.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the PapDREAM platform measure DNA methylation?",{"text":68,"@type":64},"It uses a microfluidic system performing highly parallelized digital high-resolution melt to analyze molecule-by-molecule methylation patterns near single CpG-site resolution.",{"name":70,"@type":61,"acceptedAnswer":71},"How was feasibility evaluated in the study?",{"text":72,"@type":64},"Feasibility was demonstrated by analyzing DNA from Pap specimens from a cohort of 43 women, including 18 ovarian cancer cases, using a panel of methylation biomarker loci.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341625,1790533760,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10.1002/ctm2.1778  \nRESEARCH ARTICLE  \nSingle-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer  \nChristine M. O’Keefe1   Yang Zhao1  Leslie M. Cope2, 3  Chih-Ming Ho4, 5 Amanda N. Fader6  Rebecca Stone6  James S. Ferris6  Anna Beavis6  Kimberly Levinson6, 7  Stephanie Wethington6  Tian-Li Wang2, 6, 8  Thomas R. Pisanic2, 9   Ie-Ming Shih2, 6, 8  Tza-Huei Wang1,2, 9, 10  \n1 Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA  \n2 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n3 Departments of Oncology and Biostatistics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n4 Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan  \n5 School of Medicine, Fu Jen Catholic University, New Taipei, Taiwan  \n6 Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n7 Greater Baltimore Medical Center, Towson, Maryland, USA  \n8 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n9 Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland, USA  \n10 Department of Mechanical Engineering, Johns Hopkins University, Baltimore, Maryland, USA  \nCorrespondence  \nThomas R. Pisanic, Johns HopkinsInstitute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA. Email: [tpisanic@jhu.edu](tpisanic@jhu.edu)  \nGraphical Abstract  \n∙ Ovarian cancer cells exhibit heterogeneous methylation patterns that could be leveraged as biomarkers for early detection.  \n∙ Cellular fragments and debris from ovarian tumors migrate to the cervix, where they are accessible via Pap specimen collection.  \n∙ The microfluidic HYPER-melt platform digitizes bisulfite-converted DNA into thousands of nanochambers to isolate heterogeneous epialleles, and uses digital high resolution melt to profile methylation patterns.  \n∙ A bioinformatic pipeline combines patterns from a multi-gene panel into a methylation density score that gives the probability that a given sample contains ovarian cancer DNA.  \nClin. Transl. Med. 2024;e1778 .  \n[https://doi.org/10.1002/ctm2.1778](https://doi.org/10.1002/ctm2.1778)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nO’KEEFE et al.  \nIe-Ming Shih, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.  \nEmail: [ishih@jhmi.edu](ishih@jhmi.edu)  \nTza-HueiWang, Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.  \nEmail: [thwang@jhu.edu](thwang@jhu.edu)  \nDOI: 10.1002/ctm2.1778  \nRESEARCH ARTICLE  \nSingle-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer  \nChristine M. O’Keefe1   Yang Zhao1  Leslie M. Cope2, 3  Chih-Ming Ho4, 5 Amanda N. Fader6  Rebecca Stone6  James S. Ferris6  Anna Beavis6  Kimberly Levinson6, 7  Stephanie Wethington6  Tian-Li Wang2, 6, 8  Thomas R. Pisanic2, 9   Ie-Ming Shih2, 6, 8  Tza-Huei Wang1,2, 9, 10  \n1 Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA  \n2 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n3 Departments of Oncology and Biostatistics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n4 Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan  \n5 School of Medicine, Fu Jen Catholic University, New Taipei, Taiwan  \n6 Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA  \n7 Greater Baltimore Medical Center, Towson, Maryland, USA  \n8 Department of Pathology, Johns Hopkins University School of Medicine, Balt","cbCaiibciHvTgDMm","https://ap.wps.com/l/cbCaiibciHvTgDMm","pdf",9789377,18,"English","# Research Article\n## Graphical Abstract\n## Abstract","[{\"question\":\"What problem does PapDREAM address for ovarian cancer detection?\",\"answer\":\"It targets reliable detection of rare, tumor-specific DNA methylation aberrations from low-cost, routinely collected Pap specimens, especially for early-stage disease.\"},{\"question\":\"How does the PapDREAM platform measure DNA methylation?\",\"answer\":\"It uses a microfluidic system performing highly parallelized digital high-resolution melt to analyze molecule-by-molecule methylation patterns near single CpG-site resolution.\"},{\"question\":\"How was feasibility evaluated in the study?\",\"answer\":\"Feasibility was demonstrated by analyzing DNA from Pap specimens from a cohort of 43 women, including 18 ovarian cancer cases, using a panel of methylation biomarker loci.\"}]","Single-molecule epiallelic profiling of DNA derived from routinely collected Pap specimens for noninvasive detection of ovarian cancer | PDF",1790042868,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11d944a1d910f8418dba57df6ddd6f76.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ca9d134852a27af332f855497f883d1.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a30041413fac2639fde55036eee0ac73.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2617510d9ee4db12b93d3481f86e52cd.webp",980,1287]